EOLS

Evolus, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$7.18

Price (1 Year)

$9.3 $4.01

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %25.3 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.4 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes.

Website

Analysis (Turkish): EOLS Hissesi Caiz mi, Helal mi? Evolus, Inc. Katılım Analizi